arrow_back Civic Audit
Share share

Veterans' Access to Emerging Treatments: Research Program for Chronic Conditions.

This Act mandates the Department of Veterans Affairs (VA) to establish a research and extended access program focused on innovative treatments for veterans facing chronic conditions like PTSD, chronic pain, and substance use disorders. The program facilitates veteran participation in clinical trials and compassionate access protocols involving emerging therapies, including psychedelic-assisted treatments and advanced medical devices. This aims to provide timely access to cutting-edge options where standard care is insufficient.
Key points
Veterans suffering from covered conditions (e.g., PTSD, chronic pain, TBI) gain potential access to clinical trials and experimental therapies, including psychedelic-assisted treatments (e.g., psilocybin, MDMA).
The VA must launch an investigational research program and an extended access protocol for innovative treatments within 90 days of enactment.
The program is subject to review and potential termination by the VA Secretary after two years, ensuring ongoing evaluation of safety and efficacy.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_7091
Sponsor: Rep. Bergman, Jack [R-MI-1]
Process start date: 2026-01-15
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expanding Veterans’ Access to Emerging Treatments Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_7091.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2026-01-15.

What are the main provisions?

Key points include:

  • Veterans suffering from covered conditions (e.g., PTSD, chronic pain, TBI) gain potential access to clinical trials and experimental therapies, including psychedelic-assisted treatments (e.g., psilocybin, MDMA).
  • The VA must launch an investigational research program and an extended access protocol for innovative treatments within 90 days of enactment.
  • The program is subject to review and potential termination by the VA Secretary after two years, ensuring ongoing evaluation of safety and efficacy.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Bergman, Jack [R-MI-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-28.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Benefits